Usefulness of vaccine boosters for Covid-19 in Italy and in UK and comparison between in intensive care admissions and deaths of vaccinated and unvaccinated patients. Surprises and implications

Author:

Alessandria MarcoORCID,Simion Claudio,Donzelli Alberto

Abstract

Background: There is insufficient clarity about the different outcomes between unvaccinated and vaccinated people hospitalized with Covid-19, with reference to the variables “Intensive Care Unit” and “Deaths”. Moreover, it is unclear the real effectiveness of the vaccine boosters on the risks of infection and Covid-19 deaths, beyond the first few months after the booster. To verify the hypotheses that repeated vaccinations might expose to a progressively greater risk of severe Covid-19, and of a growing weakening of the immune response, primarily against infection, as the distance from the booster dose increases. Methods: Through an analysis of the official Italian data we calculated significant differences, percentage variations and trends in the variables “Intensive Care Units” and “Deaths” in hospitalized patients among four groups with different vaccination status, and between the Unvaccinated and Vaccinated groups. Through analyses of the UK Security Agency data in the weekly COVID-19 vaccine surveillance reports we explored the vaccine effectiveness against SARS-CoV-2 infections and against COVID-19 deaths in relation to the time elapsed from the booster doses. Results: Repeated vaccinations seem to expose the recipients to a growing risk of severe Covid-19, and fewer vaccinations might be enough to protect persons at greater risk. The vaccine effectiveness against infection vanished and reversed in the medium term, and vaccinated persons with three doses become increasingly more infected versus unvaccinated persons. Conclusions: The starting hypotheses have been supported, together with the need to combine carefully rethought vaccination campaigns with the implementation of other strategies, with the achievement of a healthy living and working environment, healthy lifestyles, and effective, safe and sustainable care.

Publisher

F1000 Research Ltd

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3